Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hemophilia”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Not applicableUnknownNCT01538160
What this trial is testing

A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery

Who this might be right for
Hemophilia C
Sheba Medical Center 15
Not applicableStudy completedNCT02971969
What this trial is testing

Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Ultragenyx Pharmaceutical Inc 6
Large-scale testing (Phase 3)Study completedNCT00037544
What this trial is testing

Study Evaluating ReFacto AF in Severe Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT02634723
What this trial is testing

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 21
Large-scale testing (Phase 3)Study completedNCT01580293
What this trial is testing

A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 145
Early research (Phase 1)Study completedNCT04015492
What this trial is testing

Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)

Who this might be right for
Hemophilia A
Bayer 18
Large-scale testing (Phase 3)WithdrawnNCT02048111
What this trial is testing

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Cangene Corporation
Not applicableLooking for participantsNCT07096349
What this trial is testing

Multidimensional Assessment of Chronic Pain in Severe Haemophilia A

Who this might be right for
Hemophilia A Without Inhibitor
Investigación en Hemofilia y Fisioterapia 109
Large-scale testing (Phase 3)Study completedNCT01029340
What this trial is testing

Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A

Who this might be right for
Blood Coagulation DisordersHemophilia A
Bayer 74
Testing effectiveness (Phase 2)Study completedNCT00717626
What this trial is testing

Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
The Hospital for Sick Children 14
Not applicableStudy completedNCT00207597
What this trial is testing

Joint Outcome Study

Who this might be right for
Hemophilia A
Centers for Disease Control and Prevention 64
Not applicableStudy completedNCT01053715
What this trial is testing

Quality of Life Study of Helixate NexGen

Who this might be right for
Hemophilia A
CSL Behring 78
Post-approval studies (Phase 4)Study completedNCT04565236
What this trial is testing

A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 45
Post-approval studies (Phase 4)Active Not RecruitingNCT06752850
What this trial is testing

Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Who this might be right for
Haemophilia A (Moderate or Severe)Hemophilia, ClassicHaemophilia+3 more
Swedish Orphan Biovitrum 37
Large-scale testing (Phase 3)Study completedNCT02172950
What this trial is testing

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia ASevere Hemophilia A
CSL Behring 246
Not applicableStudy completedNCT05568524
What this trial is testing

Resistance Training With Blood Flow Restriction in Hemophilia

Who this might be right for
Hemophilia
University of Valencia 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03861273
What this trial is testing

Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 51
Not applicableStudy completedNCT01000844
What this trial is testing

Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency

Who this might be right for
Hemophilia
University of Colorado, Denver 11
Large-scale testing (Phase 3)Study completedNCT03549871
What this trial is testing

Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 80
Not applicableStudy completedNCT00166309
What this trial is testing

The FEIBA NovoSeven Comparative Study

Who this might be right for
Severe Hemophilia A With an Inhibitor
Skane University Hospital 60
Load More Results